Digital technologies are gaining traction across North America as healthcare providers seek more consistent methods for assessing diabetic ulcer progression. Digital imaging and remote monitoring can support documentation, follow-up, and communication between patients and care teams. Continued development of connected wound-care platforms may strengthen the regional market.

The Diabetic Ulcer Treatment Market is gaining momentum as the global burden of diabetes continues to increase and healthcare providers focus more strongly on preventing wound complications, infections, hospitalization, and lower-limb amputation. Advances in wound dressings, offloading technologies, negative-pressure wound therapy, biologic products, infection management, and revascularization are reshaping the treatment landscape.

The Global Diabetic Ulcer Treatment Market was valued at US$ 8.24 billion in 2025 and is expected to reach US$ 13.59 billion by 2034, recording a CAGR of 5.72% during 2026–2034. Increasing demand for advanced wound-care products and the growing adoption of multidisciplinary approaches to diabetic foot management are expected to support market expansion throughout the forecast period.

Diabetic Ulcer Treatment Market Overview

Diabetic ulcers, particularly diabetic foot ulcers (DFUs), are among the most challenging complications associated with diabetes. Peripheral neuropathy can reduce protective sensation, while peripheral artery disease, infection, impaired circulation, and elevated mechanical pressure can delay wound healing.

Treatment generally requires more than conventional wound dressing. Effective management can involve wound debridement, infection control, pressure offloading, vascular assessment, revascularization, appropriate wound dressings, and advanced wound-healing technologies.

The International Working Group on the Diabetic Foot (IWGDF) identifies offloading as a cornerstone of treatment for neuropathic plantar ulcers. Its guidance recommends appropriate non-removable knee-high offloading devices as a first-choice approach for suitable plantar forefoot and midfoot ulcers.

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00006922

Competitive Landscape

The Diabetic Ulcer Treatment Market is characterized by strong competition among global wound-care, medical-device, pharmaceutical, and healthcare companies. Leading participants are focusing on advanced dressings, negative-pressure wound therapy, biologic products, wound-management systems, vascular interventions, and technologies designed to accelerate healing.

Key companies include:

• ConvaTec Group Plc
• Solventum Corporation
• Coloplast A/S
• Smith & Nephew plc
• B. Braun SE
• Medline Industries, LP
• Medtronic plc
• Cardinal Health, Inc.
• Mölnlycke Health Care AB
• Organogenesis Holdings Inc.

Competition is increasingly shifting toward products that can improve healing outcomes, simplify wound management, reduce complications, and support limb preservation. Companies are also investing in advanced wound-care portfolios and technologies that address different stages of diabetic ulcer management.

Advanced Wound Care Drives Market Growth

One of the strongest trends in the diabetic ulcer treatment market is the growing adoption of advanced wound-care products. Traditional dressings are increasingly complemented by technologies designed to maintain an appropriate wound environment, manage exudate, protect tissue, and support healing.

Foams, hydrocolloids, alginates, antimicrobial dressings, collagen-based products, and other advanced materials are being used according to wound characteristics and clinical requirements.

The increasing prevalence of chronic and difficult-to-heal ulcers is creating demand for specialized wound-care solutions capable of supporting prolonged treatment and reducing complications.

Negative-Pressure Wound Therapy Gains Importance

Negative-pressure wound therapy (NPWT) remains an important technology within advanced wound management. The approach uses controlled negative pressure to remove wound exudate and other fluids while supporting wound management.

The FDA classifies NPWT devices as medical devices intended for wound management and reduction of wound complications.

NPWT is particularly relevant in complex wounds where conventional approaches may not provide adequate wound management. Continued technological improvements, portable systems, and greater clinical awareness are expected to contribute to the market’s development.

Offloading Becomes a Key Treatment Trend

Pressure offloading is a major focus in diabetic foot ulcer management because repetitive mechanical stress can prevent wounds from healing.

Current IWGDF guidance recommends non-removable knee-high offloading devices as the preferred approach for appropriate neuropathic plantar forefoot and midfoot ulcers. When these devices cannot be used or tolerated, removable knee-high or ankle-high alternatives may be considered.

This is creating opportunities for specialized footwear, total-contact casting, walkers, orthotic devices, and other offloading technologies.

Infection Management and Limb Salvage

Infection is another critical component of diabetic ulcer treatment. Diabetic foot infections can progress rapidly and may increase the risk of hospitalization and amputation. The FDA published final guidance in 2024 addressing the development of drugs for diabetic foot infections without bone and joint involvement, highlighting the continuing importance of innovation in this therapeutic area.

At the same time, limb-salvage strategies are gaining importance. For ulcers that fail to improve despite appropriate wound care and offloading, vascular assessment and potential revascularization become increasingly important. IWGDF guidance recommends reassessing vascular status when an ulcer does not significantly improve and considering consultation with a vascular specialist.

Biologics and Regenerative Wound Care

An emerging trend in the market is the development of biologic and regenerative wound-healing technologies. These include products involving cellular therapies, growth-factor approaches, platelet-rich plasma (PRP), tissue-based products, and other regenerative strategies.

Recent FDA biological-device records illustrate continued activity in this area. In 2026, for example, the FDA listed products involving PRP for management of cutaneous wounds including diabetic ulcers, while other technologies have been evaluated for wound debridement and chronic wound management.

Such developments could create new opportunities for companies seeking alternatives or complements to conventional wound-care products.

Rising Focus on Early Intervention

Early intervention is becoming increasingly important because diabetic ulcers can become substantially more difficult to manage when infection, ischemia, or deeper tissue involvement develops.

Healthcare systems are therefore placing greater emphasis on diabetic foot screening, preventive care, patient education, regular foot assessment, pressure management, and rapid referral to specialist wound-care teams.

Digital health and remote monitoring may also contribute to earlier identification of wound deterioration, particularly among patients requiring long-term follow-up.

Future Outlook

The Diabetic Ulcer Treatment Market is expected to maintain steady growth through 2034. The market is being shaped by increasing diabetes prevalence, the growing number of chronic wounds, advances in wound-care technologies, and greater emphasis on limb preservation.

The next phase of market development is likely to focus on advanced dressings, NPWT, smart wound-care technologies, biologic products, regenerative medicine, offloading solutions, infection management, and personalized wound treatment.

Also Available in: Korean | German | Japanese | French | Chinese | Italian | Spanish

Related Reports:

Negative Pressure Wound Therapy Devices Market Size, Growth & Demand by 2034

Wound Closure Devices Market Dynamics, Recent Developments, and Strategic Insights by 2031

About Us

The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.

Contact Us

Contact Person: Ankit Mathur

Phone: +1-646-491-9876

E-mail : sales@theinsightpartners.com